First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

被引:342
|
作者
Ghinai, Isaac [1 ,7 ]
McPherson, Tristan D. [1 ,8 ]
Hunter, Jennifer C. [2 ]
Kirking, Hannah L. [3 ]
Christiansen, Demian [9 ]
Joshi, Kiran [9 ]
Rubin, Rachel [9 ]
Morales-Estrada, Shirley [9 ]
Black, Stephanie R. [8 ]
Pacilli, Massimo [8 ]
Fricchione, Marielle J. [8 ]
Chugh, Rashmi K. [10 ]
Walblay, Kelly A. [8 ]
Ahmed, N. Seema [11 ]
Stoecker, William C. [11 ]
Hasan, Nausheen F. [12 ]
Burdsall, Deborah P. [7 ]
Reese, Heather E. [1 ,4 ]
Wallace, Megan [1 ,3 ]
Wang, Chen [13 ,14 ]
Moeller, Darcie [13 ,14 ]
Korpics, Jacqueline [13 ,14 ]
Novosad, Shannon A. [2 ]
Benowitz, Isaac [2 ]
Jacobs, Max W. [5 ,15 ]
Dasari, Vishal S. [6 ,16 ]
Patel, Megan T. [7 ]
Kauerauf, Judy [7 ]
Charles, E. Matt [7 ]
Ezike, Ngozi O. [7 ]
Chu, Victoria [1 ,3 ]
Midgley, Claire M. [3 ]
Rolfes, Melissa A. [5 ]
Gerber, Susan I. [3 ]
Lu, Xiaoyan [3 ]
Lindstrom, Stephen [3 ]
Verani, Jennifer R. [4 ]
Layden, Jennifer E. [8 ]
机构
[1] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
[4] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
[5] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
[6] Ctr Dis Control & Prevent, One Hlth Off, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA
[7] Illinois Dept Publ Hlth, Springfield, IL 62761 USA
[8] Chicago Dept Publ Hlth, Chicago, IL USA
[9] Cook Cty Dept Publ Hlth, Oak Forest, IL USA
[10] DuPage Cty Hlth Dept, Wheaton, IL USA
[11] Metro Infect Dis Consultants, Burr Ridge, IL USA
[12] Premier Primary Care Phys, Carol Stream, IL USA
[13] Cook Cty Hlth, Chicago, IL USA
[14] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[15] Lake Erie Coll Osteopath Med, Erie, PA USA
[16] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA
来源
LANCET | 2020年 / 395卷 / 10230期
关键词
D O I
10.1016/S0140-6736(20)30607-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated the first case of COVID-19 in Illinois, USA. Methods Patients with confirmed COVID-19 were defined as those with a positive SARS-CoV-2 test. Contacts were people with exposure to a patient with COVID-19 on or after the patient's symptom onset date. Contacts underwent active symptom monitoring for 14 days following their last exposure. Contacts who developed fever, cough, or shortness of breath became persons under investigation and were tested for SARS-CoV-2. A convenience sample of 32 asymptomatic health-care personnel contacts were also tested. Findings Patient 1-a woman in her 60s-returned from China in mid-January, 2020. 1 week later, she was hospitalised with pneumonia and tested positive for SARS-CoV- 2. Her husband (Patient 2) did not travel but had frequent close contact with his wife. He was admitted 8 days later and tested positive for SARS-CoV-2. Overall, 372 contacts of both cases were identified; 347 underwent active symptom monitoring, including 152 community contacts and 195 health-care personnel. Of monitored contacts, 43 became persons under investigation, in addition to Patient 2. These 43 persons under investigation and all 32 asymptomatic health-care personnel tested negative for SARS-CoV-2. Interpretation Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while Patient 1 was symptomatic. Despite active symptom monitoring and testing of symptomatic and some asymptomatic contacts, no further transmission was detected.
引用
收藏
页码:1137 / 1144
页数:8
相关论文
共 50 条
  • [21] Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
    Tang, J. W.
    Bahnfleth, W. P.
    Bluyssen, P. M.
    Buonanno, G.
    Jimenez, J. L.
    Kurnitski, J.
    Li, Y.
    Miller, S.
    Sekhar, C.
    Morawska, L.
    Marr, L. C.
    Melikov, A. K.
    Nazaroff, W. W.
    Nielsen, P., V
    Tellier, R.
    Wargocki, P.
    Dancer, S. J.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 89 - 96
  • [22] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy
    Cevik, Muge
    Marcus, Julia L.
    Buckee, Caroline
    Smith, Tara C.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 : S170 - S176
  • [23] Airborne Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): What We Know
    Samet, Jonathan M.
    Prather, Kimberly
    Benjamin, Georges
    Lakdawala, Seema
    Lowe, John-Martin
    Reingold, Arthur
    Volckens, John
    Marr, Linsey C.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (10) : 1924 - 1926
  • [24] The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam
    Pham Quang Thai
    Rabaa, Maia A.
    Duong Huy Luong
    Dang Quang Tan
    Tran Dai Quang
    Ha-Linh Quach
    Ngoc-Anh Hoang Thi
    Phung Cong Dinh
    Ngu Duy Nghia
    Tran Anh Tu
    La Ngoc Quang
    Tran My Phuc
    Vinh Chau
    Nguyen Cong Khanh
    Dang Duc Anh
    Tran Nhu Duong
    Thwaites, Guy
    H Rogier van Doorn
    Marc Choisy
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (09) : E334 - E342
  • [25] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
    De Felice, Fernanda G.
    Tovar-Moll, Fernanda
    Moll, Jorge
    Munoz, Douglas P.
    Ferreira, Sergio T.
    TRENDS IN NEUROSCIENCES, 2020, 43 (06) : 355 - 357
  • [26] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis
    Charlotte Steenblock
    Vladimir Todorov
    Waldemar Kanczkowski
    Graeme Eisenhofer
    Andreas Schedl
    Ma-Li Wong
    Julio Licinio
    Michael Bauer
    Allan H. Young
    Raul R. Gainetdinov
    Stefan R. Bornstein
    Molecular Psychiatry, 2020, 25 : 1611 - 1617
  • [27] Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
    Pecetta, Simone
    Kratochvil, Sven
    Kato, Yu
    Vadivelu, Kumaran
    Rappuoli, Rino
    PHARMACOLOGICAL REVIEWS, 2022, 74 (01) : 313 - 339
  • [28] A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Larson, Derek
    Brodniak, Sterling L.
    Voegtly, Logan J.
    Cer, Regina Z.
    Glang, Lindsay A.
    Malagon, Francisco J.
    Long, Kyle A.
    Potocki, Ronald
    Smith, Darci R.
    Lanteri, Charlotte
    Burgess, Timothy
    Bishop-Lilly, Kimberly A.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2827 - E2828
  • [29] The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations
    Lippi, Giuseppe
    Henry, Brandon M.
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [30] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis
    Steenblock, Charlotte
    Todorov, Vladimir
    Kanczkowski, Waldemar
    Eisenhofer, Graeme
    Schedl, Andreas
    Wong, Ma-Li
    Licinio, Julio
    Bauer, Michael
    Young, Allan H.
    Gainetdinov, Raul R.
    Bornstein, Stefan R.
    MOLECULAR PSYCHIATRY, 2020, 25 (08) : 1611 - 1617